The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
MicroRNAs as non-invasive biomarkers of heart transplant rejection
Abstract
AIM: Rejection is one of the major causes of late cardiac allograft failure and at present can only be diagnosed by invasive endomyocardial biopsies. We sought to determine whether microRNA profiling could serve as a non-invasive biomarker of cardiac allograft rejection. METHODS: We included 113 heart transplant recipients from four referral French institutions (test cohort, n = 60, validation cohort, n = 53). In the test cohort, we compared patients with acute biopsy-proven allograft rejection (n = 30) to matched control patients without rejection (n = 30), by assessing microRNAs expression in the heart allograft tissue and patients concomitant serum using RNA extraction and qPCR analysis. Fourteen miRNAs were selected on the basis of their implication in allograft rejection, endothelial activation, and inflammation and tissue specificity. RESULTS: We identified seven miRNAs that were differentially expressed between normal and rejecting heart allografts: miR-10a, miR-21, miR-31, miR-92a, miR-142-3p miR-155, and miR-451 (P < 0.0001 for all comparisons). Four out of seven miRNAs also showed differential serological expression (miR-10a, miR-31, miR-92a, and miR-155) with strong correlation with their tissular expression. The receiver-operating characteristic analysis showed that these four circulating miRNAs strongly discriminated patients with allograft rejection from patients without rejection: miR-10a (AUC = 0.975), miR-31 (AUC = 0.932), miR-92a (AUC = 0.989), and miR-155 (AUC = 0.998, P < 0.0001 for all comparisons). We confirmed in the external validation set that these four miRNAs highly discriminated patients with rejection from those without. The discrimination capability of the four miRNAs remained significant when stratified by rejection diagnosis (T-cell-mediated rejection or antibody-mediated rejection) and time post-transplant. CONCLUSION: This study demonstrates that a differential expression of miRNA occurs in rejecting allograft patients, not only at the tissue level but also in the serum, suggesting their potential relevance as non-invasive biomarkers in heart transplant rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
Methodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436 · cited 1×
“Finally, we determined fold values for each sample (2 ).(26,27)”
MethodUrinary-cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts
Suthanthiran, M., Schwartz, J. E., Ding, R., Abecassis, M., Dadhania, D., Samstein, B., Knechtle, S. J., Friedewald, J., Becker, Y. T., Sharma, V. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215555 · Cited by 363
Cited by
Velleca, A., Shullo, M. A., Dhital, K., Azeka, E., Colvin, M., DePasquale, E., Farrero, M., García-Guereta, L., Jamero, G., Khush, K., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.015 · Cited by 645
Antibody-Mediated Rejection of Solid-Organ Allografts
Loupy, A., & Lefaucheur, C. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1802677 · Cited by 549
Self-citationCirculating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury
Viereck, J., & Thum, T. (2017) · Circulation Research · doi:10.1161/circresaha.116.308434 · Cited by 374
Opportunities for microRNAs in the crowded field of cardiovascular biomarkers
Halushka, P. V., Goodwin, A. J., & Halushka, M. K. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012827 · Cited by 84
Blocking of targeted microRNAs from next-generation sequencing libraries
Roberts, B. S., Hardigan, A. A., Kirby, M. K., Fitz-Gerald, M. B., Wilcox, C. M., Kimberly, R. P., & Myers, R. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv724 · Cited by 8
Metadata
- Authors
- Duong Van Huyen, J.-P., Tible, M., Gay, A., Guillemain, R., Aubert, O., Varnous, S., Iserin, F., Rouvier, P., Francois, A., Vernerey, D., Loyer, X., Leprince, P., Empana, J.-P., Bruneval, P., Loupy, A., & Jouven, X.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-31
- Volume
- 35
- Issue
- 45
- Pages
- 3194-3202
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2130485791
- Cited by
- 197
- References
- 5
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNAs as non-invasive biomarkers of heart transplant rejection. https://app.cochat.ai/papers/10.1093/eurheartj/ehu346
- The paper
- Duong Van Huyen, J.-P., Tible, M., Gay, A., Guillemain, R., Aubert, O., Varnous, S., Iserin, F., Rouvier, P., Francois, A., Vernerey, D., Loyer, X., Leprince, P., Empana, J.-P., Bruneval, P., Loupy, A., & Jouven, X. (2014). MicroRNAs as non-invasive biomarkers of heart transplant rejection. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.